Reuters logo
BRIEF-Puma Biotechnology's marketing authorization application for neratinib validated by EMA
August 22, 2016 / 8:51 PM / a year ago

BRIEF-Puma Biotechnology's marketing authorization application for neratinib validated by EMA

Aug 22 (Reuters) - Puma Biotechnology Inc :

* Marketing authorization application for neratinib has been validated by European Medicines Agency Source text (bit.ly/2bxvgWa) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below